


The Fund's investment objective is to provide long term capital growth by matching the capital performance of the FTSE World Europe excluding UK Index.
| Name | % Net Assets |
|---|---|
| Nestle S.A. | 4.8% |
| Novartis AG | 3.3% |
| Roche Holding AG Part. Cert. | 2.7% |
| Total S.A. | 2.3% |
| Sanofi | 2.2% |
| Siemens AG | 1.8% |
| BASF AG | 1.6% |
| Sanofi-Aventis S.A. | 1.4% |
| LVMH Moet Hennessy Louis Vuitton SA | 1.3% |
| Anheuser-Busch InBev | 1.3% |
| Key | % Net Assets |
|---|---|
| 4.8% | |
| 3.3% | |
| 2.7% | |
| 2.3% | |
| 86.9% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 1,700.00p |
| Currency | GBP |
| Change | 3.00p |
| % | 0.18% |
| YTD change | 258.00p |
| YTD % | 17.89% |
| Fund Inception | 14/01/1989 |
|---|---|
| Fund Manager | Sinopia Asset Management (UK) Ltd |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £1,000,000 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.11 |
You are here: research